The Medical Device Regulation, Regulation (EU) 2017/745, is the primary law governing medical devices in the European Union. It applied from 26 May 2021, replacing the earlier Medical Device Directive and Active Implantable Medical Device Directive. The MDR tightened requirements across the board: stricter clinical evidence, reclassification of many devices into higher risk classes, expanded roles for notified bodies, unique device identification, and a central database called EUDAMED. Manufacturers must demonstrate conformity through clinical evaluation and post-market surveillance, and appoint a person responsible for regulatory compliance. Software with a medical purpose falls within scope and is classified according to the harm its information can cause. Transitional provisions have been extended several times to ease notified body capacity constraints, so the effective dates for legacy devices depend on their risk class and certificate status.
What is the EU MDR?
The EU Medical Device Regulation (EU) 2017/745, the framework governing the safety and market access of medical devices in the European Union.
When did the MDR come into force?
The MDR entered into application on 26 May 2021, after a transition from the previous Medical Device Directive. Extended transitional deadlines apply to certain legacy devices depending on their risk class.
What is the difference between the MDR and IVDR?
The MDR covers general medical devices, while the IVDR, Regulation (EU) 2017/746, covers in vitro diagnostic devices such as tests and assays. They are parallel regulations with similar structures but different classification rules.
Food Standards of Identity Modernization; Pasteurized Orange Juice
The Food and Drug Administration (FDA or we) is issuing a final rule to amend the standard of identity for pasteurized orange juice by lowering the minimum orange juice soluble solids content from 10.5[deg] to 10[deg]...
US Federal Register - FDA RulesPMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – July 2026
23 Jul 2026 PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – July 2026 Online Start date: 23 July 2026, 09:30 (CEST) End date: 23 July 2026, 10:30 (CEST)
EMA - European Medicines AgencyLa AEMPS informa de la retirada de un lote del medicamento veterinario Tessie 0,3 mg/ml solución oral para perros
Generar PDF Fecha de publicación: 17 de julio de 2026 Categoría: medicamentos veterinarios, defectos de calidad Referencia: Alerta VDC, 04/2026 La retirada se ha producido por la ausencia en el embalaje exterior de la...
AEMPS (Spanish Medicine Agency)La AEMPS informa sobre el nuevo Sistema de Evaluación de Tecnologías Sanitarias tras la aprobación del Real Decreto 415/2026
Generar PDF Fecha de publicación: 17 de julio de 2026 Categoría: la AEMPS Referencia: AEMPS, 15/2026 La Agencia actuará como Oficina de Evaluación de Medicamentos y participará activamente en la gobernanza del nuevo S...
AEMPS (Spanish Medicine Agency)La AEMPS informa del robo y distribución ilegal de dos lotes de sensores Dexcom G7
Generar PDF Fecha de publicación: 17 de julio de 2026 Categoría: productos sanitarios, seguridad Referencia: PS, 31/2026 Los lotes 1725204004 y 1725069002 de los sensores Dexcom G7 han sido robados y puestos a la vent...
AEMPS (Spanish Medicine Agency)